New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
A new Chinese venture group looking to bridge therapeutics into the big Asian market led a $10 million startup round for a Boston-based biotech upstart …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.